Featured
Breast cancer screening becomes more personalized with risk-based guidelines
Drug Approvals Oct 25, 2026
Clinic Moves Oct 24, 2026
Trial Briefs Oct 23, 2026
Vaccine shows promise in generating immune response to KRAS mutations in pancreatic cancer study.
Five U.S. hospitals rank among the world’s top oncology centers in 2027, showcasing one of...
The FDA approves ropeginterferon alfa-2b-njft for essential thrombocythemia, the first new treatment for the rare...
Read our latest Drug Approvals articles.
Personalized breast cancer screening guidelines are replacing one-size-fits-all approaches, offering tailored plans based on individual...
Therapeutic phlebotomy is one of the key treatments for managing polycythemia vera risks, helping lower...
Most breast bruises are not linked to breast cancer unless they persist beyond two weeks,...
Personalized breast cancer screening guidelines are replacing one-size-fits-all approaches, offering tailored plans based on individual risk factors and history
Personalized breast cancer screening guidelines are replacing one-size-fits-all approaches, offering tailored plans based on individual risk factors and history
Vaccine shows promise in generating immune response to KRAS mutations in pancreatic cancer study.
Rare chest tumor treatment for a 55-year-old Montana woman with a family history of heart disease, treated via integrated care...
Mayo Clinic explores low-dose radiation as a potential way to slow Parkinson’s progression by targeting brain inflammation in early-stage patients...
Managing anxiety and uncertainty in polycythemia vera is possible with these coping strategies. Learn how patients handle stress and keep...
Five U.S. hospitals rank among the world’s top oncology centers in 2027, showcasing one of the strongest cancer treatment networks...
Managing fatigue with polycythemia vera involves balancing energy levels and daily activities to maintain well-being while participating in life's pursuits.
Long-term, stage-based journey of multiple myeloma treatment, understanding what to expect at each phase.
New myelofibrosis treatments offer hope and improve quality of life, with patient-focused strategies from the NCCN guiding management.
Therapeutic phlebotomy is one of the key treatments for managing polycythemia vera risks, helping lower hematocrit levels below 45% to...